BioSpace News Archive

Policy

Paxlovid, Remdesivir Win New Recommendations from WHO

The WHO has indicated support for Pfizer’s Paxlovid and reversing a previous decision on using antiviral remdesivir, now recommending it in cases of mild to moderate COVID-19.

April 22, 2022
·
2 min read
·
Jazmine Colatriano
Drug Development

Faron Touts Positive Results of Bexmarilimab in Refractory Melanoma Patients

Faron Pharmaceuticals announced a new analysis that estimates 100% overall survival at 12-months for patients who experienced clinical benefit following treatment with bexmarilimab.

April 22, 2022
·
2 min read
·
Geoff Herman
Drug Development

Frenkl and Roth Together Again as Bayer Builds Oncology Powerhouse

Bayer has lured another top oncology expert from GlaxoSmithKline. Tara Frenkl is joining the Germany-based life sciences giant as the new head of oncology development.

April 22, 2022
·
3 min read
·
Alex Keown
Business

60 Scientists Sign Letter Petitioning FDA for T Cell Recognition

As Omicron dominates the COVID-19 landscape, scientists are urging the FDA to reconsider how the agency defines immune responses.

April 22, 2022
·
4 min read
·
Hannah Chudleigh
Policy

Biogen Gives Up on EU Approval of Aduhelm Following CHMP Opinion

Biogen has withdrawn its Marketing Authorization Application (MAA) for European approval of Aduhelm after regulators hinted data was not strong enough to support potential approval.

April 22, 2022
·
3 min read
·
Alex Keown
Policy

Louisiana AG Sues UnitedHealth Group Over Alleged Medicaid Fraud

Louisiana Attorney General Jeff Garland sued UnitedHealth Group over Medicaid fraud. In a lawsuit filed earlier this week, Garland alleged the insurance company overinflated drug charges.

April 22, 2022
·
3 min read
·
Alex Keown
Drug Development

Long COVID vs Persistent COVID: What’s the Difference?

Long COVID is loosely defined as COVID-19 symptoms that persist for longer than four weeks from an initial diagnosis. Here’s a look at the latest in long COVID research.

April 22, 2022
·
4 min read
·
Mark Terry
Employer Resources

Employee Retention: How to Get Staff to Stick Around

Most employers are well aware of the devastating effects the pandemic has had on employee retention. Read on to find out how long you can expect your staff to stay and how to keep them.

April 22, 2022
·
5 min read
·
Franklin Carpenter
Drug Development

Astellas Abandons DMD Gene Therapy Program, Loses $390M

Today, Astellas announced that after evaluating its gene therapy for patients with X-linked Myotubular Myopathy, it revised its eligible treatment population and any likely future product label.

April 22, 2022
·
3 min read
·
Mark Terry
Business

A Look at where Biopharma Bucks are Going in 2022

Although treating patients is the top priority of the biopharma industry, there’s no doubt that money is the driver. This is a broad look at the current state of biopharma bucks.

April 22, 2022
·
4 min read
·
Mark Terry